It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus ...

It said: The last five years have been particularly challenging for CSL, with the business navigating material inflationary pressures to its plasma collections costs, the threat of a new entrant ...

MONTREAL, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The CSL Group (“CSL”), a global leader in responsible marine transportation, is proud to be named one of Canada’s Top Employers for Young People ...

SCOTTSDALE, Ariz., January 22, 2025--Carlisle Companies Incorporated (NYSE:CSL) will release fourth quarter 2024 results on Tuesday, February 4, 2025, after market close. A conference call to ...

Carlisle Companies Incorporated operates as a manufacturer and supplier of building envelope products and solutions in the United States, Europe, North America, Asia and the Middle East, Africa ...

Gift 5 articles to anyone you choose each month when you subscribe. American trade negotiators tried to break local biotech CSL’s control of the Australian blood plasma market, in a move that ...

After hours: January 28 at 5:05:01 PM EST Loading Chart for CSL ...

What just happened? China's Experimental Advanced Superconducting Tokamak (EAST), nicknamed the artificial sun, has shattered its own world record for plasma confinement. On Monday, EAST ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.